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Lymphatic vessels (LVs) are important structures for
antigen presentation, for lipid metabolism, and as
conduits for tumor metastases, but they have been
difficult to visualize in vivo. Prox1 is a transcription
factor that is necessary for lymphangiogenesis in on-
togeny and the maintenance of LVs. To visualize LVs
in the lymph node of a living mouse in real time, we
made the ProxTom transgenic mouse in a C57BL/6
background using red fluorescent LVs that are suit-
able for in vivo imaging. The ProxTom transgene con-
tained all Prox1 regulatory sequences and was faith-
fully expressed in LVs coincident with endogenous
Prox1 expression. The progenies of a ProxTom 
Hec6stGFP cross were imaged using two-photon laser
scanning microscopy, allowing the simultaneous vi-
sualization of LVs and high endothelial venules in a
lymph node of a living mouse for the first time. We
confirmed the expression of Prox1 in the adult liver,
lens, and dentate gyrus. These intensely fluorescent
mice revealed the expression of Prox1 in three novel
sites: the neuroendocrine cells of the adrenal me-
dulla, megakaryocytes, and platelets. The novel sites
identified herein suggest previously unknown roles
for Prox1. The faithful expression of the fluorescent
reporter in ProxTom LVs indicates that these mice
have potential utility in the study of diseases as di-
verse as lymphedema, filariasis, transplant rejection,
obesity, and tumor metastasis. (Am J Pathol 2012, 180:
1715–1725; DOI: 10.1016/j.ajpath.2011.12.026)Lymphatic vessels (LVs) are important structures for an-
tigen presentation, fluid homeostasis, and lipid metabo-
lism and as conduits for tumor metastases. Despite their
importance, research into LVs has fallen behind that of
arteries and veins because these thin-walled vessels
have been difficult to visualize in vivo. Only recently have
specific markers for LVs become available. Ultimately,
we have been frustrated by our inability to evaluate dy-
namic LV functions, such as lymphangiogenesis and
lymph node remodeling in real time, in live mice.
We have shown that after immunization, dramatic
changes occur in LVs and high endothelial venules
(HEVs) of the lymph node.1 To further understand these
changes, our goal was to visualize LVs and HEVs simul-
taneously in a living lymph node. We decided to develop
a fluorescent red lymphatic reporter mouse in C57BL/6
mice for two-photon laser scanning microscopy in vivo
imaging. We chose the C57BL/6 background as partic-
ularly appropriate for cell transfer experiments requiring
inbred mice.
The goal was to cross the red LV reporter mice with
Hec6stGFP mice that have green fluorescent protein
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in vivo imaging.2
The discovery of markers of lymphatic endothelium,
such as Prox1 (prospero-related homeobox gene-1),
LYVE-1 (lymphatic vessel endothelial hyaluronan recep-
tor-1), and podoplanin (gp38), has accelerated lymphatic
research.3–6 However, deletion of any of these lymphatic
genes results in embryonic lethality (eg, Prox1, Sox18,
and podoplanin).6 Reporters driven by podoplanin or
VEGFR3 are suboptimal because they fail to reproduce
the expression pattern of the endogenous genes in LVs.
The conditional expression of GFP under the control of
LYVE-1 labeled a population of lymph node macro-
phages in addition to LVs.7 The expression of GFP in the
macrophages of these LYVE-1–driven reporter mice
makes them unsuitable for the study of lymphangiogen-
esis in lymph nodes.
A transgene consisting of 4 kb of the Prox1 promoter
driving GFP expresses the reporter in embryonic LVs, but
it is unclear whether GFP is seen in adult LVs.8 This 4-kb
construct has a short upstream regulatory segment that
lacks two important binding sites for the transcription
factor COUP-TFII. COUP-TFII is required for initiation and
maintenance of Prox1 in LVs.9 Recently, a different
mouse line transgenic for Prox1 driving GFP was re-
ported to have fluorescent green LVs.10 This mouse was
originally made by the GENSAT (Gene Expression Ner-
vous System Atlas) program, which was a large-scale
effort to incorporate GFP reporters into neuronal genes.
This GFP reporter mouse is on the outbred [FVB/N-Crl:
CD1 (ICR)] background and is not appropriate for immu-
nologic studies, which require a pure inbred background.
We designed the “ProxTom” LV reporter mice to take
advantage of the many knockout and transgenic lines,
including our own Hec6stGFP mice, which are on the
C57BL/6 background. To date, both of the published
fluorescent lymphatic reporter mice use GFP, so we de-
liberately chose to make a red fluorescent LV reporter
mouse that would be suitable to cross with the
Hec6stGFP mouse that has green fluorescent HEVs.2
Furthermore, GFP has lower fluorescence intensity and a
shorter half-life than does tdTomato, and it is not known
whether the GENSAT mouse is suitable for in vivo imaging
of LVs.10
To make the ProxTom LV reporter mice, we selected
the gene for the homeobox-like transcription factor Prox1
to drive the red fluorescent protein (RFP) tdTomato.11
Prox1 is the mammalian homolog of the Drosophila ho-
meobox gene prospero. In mammals, Prox1 is necessary
for formation of the lymphatic system3 and development
of the murine lens,12 liver,13 and dentate gyrus.14 We
chose Prox1 because it is a “master regulator” of LVs in
ontogeny and into maturity. Prox1 is sufficient to drive
veins toward a lymphatic phenotype in vitro and in vivo.15
LVs develop after the embryonic blood vessels have
formed by sprouting from the cardinal vein.16 On day
E9.5, a subset of endothelial cells lying in the wall of the
cardinal vein start to express Prox1. These Prox1-ex-
pressing cells form the lymphatic sac that eventually
buds off and separates from the vein to become mature
LVs. This process of lymphatic differentiation is arrestedin Prox1-deficient embryos, which die at day E15 with
blood-filled lymphatics due to persistent connections be-
tween LVs and veins.3
Recent reports show that platelets are involved in lym-
phangiogenesis and are required for separation of the
lymphatic sac from the cardinal vein.17–22 Mice that have
a targeted depletion of megakaryocytes, which are the
source of platelets, also fail to divide their lymphatic and
venous vasculatures and have abnormal, persistent LV-
venous connections that result in blood-filled lymphat-
ics.17 Knockout mice lacking podoplanin, C-type lectin-
like receptor (CLEC)-2, or its signaling partners SYK and
SLP-76 also fail to separate LVs from veins and have
blood-filled lymphatics.18,19 This finding indicates that
platelets must activate the CLEC2/SYK/SLP-76 pathway
to separate the lymphatics from the cardinal vein. It is
unknown how platelets contribute to this separation, but it
has been suggested that platelets expressing CLEC2
can bind to podoplanin and aggregate to form a plug that
physically divides the two systems.17,20 However, integ-
rin 2/ mice that cannot form a platelet plug have LVs
that develop normally, implying that a physical platelet
plug may not be critical for the separation of lymphatics
from veins.22 So far, it has been impossible to observe
these events in vivo, to visualize lymphangiogenesis in
inflammation, or to visualize LVs in living mice; this drove
us to develop the ProxTom mice. The high visibility of the
tdTomato reporter allowed us to reliably image LVs, and
we show images of HEVs and LVs captured simultane-
ously in vivo for the first time.
We show that the transgene was expressed in LVs
coincident with the endogenous Prox1 protein. We con-
firmed Prox1 expression in the adult liver, lens, and den-
tate gyrus as previously described.12–14 We also report
that Prox1 is expressed by cells in three novel places: the
adrenal medulla, CD41 megakaryocytes, and platelets.
Prox1 was located in the megakaryocyte cytoplasm, from
where it could be incorporated into platelets.
Herein we describe the ProxTom transgenic mouse,
with its brightly fluorescent LVs. The intense fluores-
cence of ProxTom LVs means that these animals have
great potential for studying diseases as diverse as
lymphedema, filariasis, transplant rejection, obesity, and
tumor metastasis.
Materials and Methods
Mice
ProxTom transgenic mice were made by pronuclear mi-
croinjection of C57BL/6-fertilized ova by Animal Genomic
Services, Section of Comparative Medicine, Yale Univer-
sity School of Medicine, New Haven, CT. Hec6stGFP
mice that express GFP in HEVs have been described
previously.2 C57BL/6 mice were obtained from The Jack-
son Laboratory (Bar Harbor, ME). The Yale University
Institutional Animal Care and Use Committee approved
all animal use.
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and Southern Blot Analysis
A 143,990-bp genomic fragment containing the Prox1
gene and flanking regions was captured in pClasper
by homologous recombination in yeast. The pClasper
method for construction of transgenes, using a yeast-
bacteria shuttle vector, has been described.23 Genomic
information necessary for designing the transgene was ob-
tained from the National Center for Biotechnology Informa-
tion Mouse Genome Resources database. The ProxTom
transgene is based on a 214,895-bp BAC clone, RPCI-23-
385H16 (Invitrogen, Carlsbad, CA), corresponding to nu-
cleotides 191,782,085 to 191,996,980 of mouse chromo-
some 1 (National Center for Biotechnology Information
Mouse Genome Build 37.1). A 143,990-bp genomic frag-
ment, representing nucleotides 23,399 to 167,389 of
RPCI23-385H16, containing the Prox1 gene and flank-
ing regions was captured in pClasper by homologous
recombination in yeast. The Prox1 gene was modified
by insertion of a promoterless tdTomato RFP reporter
gene (a gift from Roger Y. Tsien, University of Califor-
nia, San Diego, CA)11,23 in-frame after the DNA coding
for amino acid five (Asp5), which is upstream of the
Prox1 nuclear localization signal (Figure 1A). Trans-
gene-positive mice were identified by PCR of DNA from
tail biopsy samples using ProxseqF and ProxseqR
primers that amplify a 933-bp product. The number of
copies of the transgene inserted in founder mice was ana-
lyzed by Southern blot analysis. EcoRV-digested genomic
tail DNA from founder numbers 12 and 15 was probed with
a 1132-bp 32P-dCTP–labeled URA3 probe that hybridized
to a 5164-bp fragment in the reporter gene cassette (Figure
1, B and C). Oligonucleotides used for the construction and
molecular analysis of the ProxTom transgene in transgenic
mice are listed in Table 1.
Fluorescent Immunohistochemical Analysis
Tissues were fixed in periodate-lysine–1% paraformal-
dehyde, embedded in OCT, and stored at 80°C. The
7-m–thick frozen sections were cut and blocked with
4% serum (Sigma-Aldrich, St. Louis, MO) and 5% bo-
vine serum albumin in PBS. Primary antibodies: rabbit
anti-RFP 1:500 (Rockland Antibodies & Assays, Gil-
bertsville, PA), rabbit anti-Prox1 1:100 (Abcam Inc.,
Cambridge, MA), rabbit anti-mouse Prox1 1:100 (An-
gioBio, Del Mar, CA), rat anti–LYVE-1 1:250 (R&D Sys-
tems, Minneapolis, MN), fluorescein isothiocyanate rat
anti-mouse CD11b 1:200 (BD Pharmingen, San Diego,
CA), rabbit anti-mouse tyrosine hydroxylase 1:500 (Ab-
cam Inc.), mouse anti-human VE-cadherin 1:200
(Santa Cruz Biotechnology, Santa Cruz, CA), rat anti-
mouse CD41 1:50, and rat isotype control (R&D Sys-
tems). Secondary antibodies: biotinylated goat anti-rabbit
IgG 1:300 (Vector Laboratories, Burlingame, CA), strepta-
vidin-CY3 1:500 (Jackson ImmunoResearch Laborato-
ries, Inc., West Grove, PA), streptavidin-CY2 1:500
(Jackson ImmunoResearch Laboratories, Inc.), goat
anti-mouse Dylight488 (Jackson ImmunoResearch Lab-oratories, Inc.), donkey anti-rabbit IgG Dylight 549 1:1000
(Jackson ImmunoResearch Laboratories, Inc.), goat anti-
rabbit 488 (Alexa Fluor; Molecular Probes Inc., Eugene,
Figure 1. Construction of the ProxTom transgene, genotyping, and
Southern blot analysis of ProxTom mice. A: Diagram of the ProxTom
transgene. Approximately 144 kb of BAC clone RPCI23-385H16 (215 kb)
containing the mouse Prox1 gene, including 80 kb of upstream flanking
sequence, was captured in pClasper by homologous recombination in
yeast. A promoterless tdTomato reporter gene was mated to the
SV40polyA signal and the yeast gene, URA3, to select for pCLA-ProxTom
yeast transformants. The reporter cassette was inserted in-frame after
amino acid five (Asp5) of the Prox1 gene in pCLA-Prox1 (152,609 bp) to
produce pCLA-Prox1-Tom (155,546 bp) by yeast recombination. Asp5 is
upstream of the nuclear localization sequence in Prox1 and leads to
default expression of tdTomato in the cell’s cytoplasm. The ProxseqF and
ProxseqR primers used for genotyping are shown. B: A 933-bp product
was amplified in ProxTom-positive founders (4, 12, and 15) but not in
negative littermates (1, 10, 23, and 27). The ProxTom transgene construct
was used as a positive control (pos), and genomic DNA from C57BL/6 and
no DNA were negative controls (neg). C: Southern blot analysis of EcoRV-
digested genomic tail DNA from founders 12 and 15 was probed with a 1132-bp
32P-dCTP–labeled URA3 probe hybridizing to a 5164-bp fragment. Dilutions of
the transgene DNA are shown to estimate the number of copies of the transgene
inserted into each mouse. Founders 12 (eight to ten copies) and 15 (five to six
copies) had only one integration site each.OR), and goat anti-rat CY2 1:100 (Jackson ImmunoRe-
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using an Axiocam camera (Carl Zeiss MicroImaging
GmbH, Jena, Germany) mounted directly onto the micro-
scope. Images were analyzed and size bars were calcu-
lated using Axiovision software (Carl Zeiss MicroImaging
GmbH). Images were saved in the TIFF format. Red,
green, and blue images were merged using Photoshop
version 8.0 (Adobe Systems Inc., San Jose, CA).
In Vivo Two-Photon Laser Scanning
Microscopy and Three-Dimensional Volume
Rendering of Lymph Nodes in Living Mice
For in vivo imaging of an exposed lymph node, progenies of
a cross between Hec6stGFP and ProxTom mice (progeny
of founder 12) were immunized by skin painting with 50 L
of 4% oxazolone (4-ethoxymethylene-2-phenyl-2-oxazolin-
5-one; Sigma-Aldrich) in acetone on the hind leg. Seven
days later, anesthesia was induced by an i.p. injection of
200 L of 10 mg/mL ketamine and 1 mg/mL xylazine (Fort
Dodge Animal Health, Fort Dodge, IA) and was maintained
by an inhaled isofluorane and air mixture. The mouse was
immobilized on a custom-built stage, and the right popliteal
Table 1. Oligonucleotides Used in this Study
Oligo name
Construction o
5PROXC Nucleotides 1–50 correspond to pCla
23,399–23,448 of RPCI23-385H16.
5=-AGGAGTCATATTACCCTGTTATCCCTA
TGCATTGGGTATAGGGTACCCATC-3=
5PROXCRC Reverse complement of 5PROXC.
5=-GATGGGTACCCTATACCCAATGCAGGA
GGATAACAGGGTAATATGACTCTCT-3
3PROXC Nucleotides 1–50 correspond to nucle
correspond to pClasperA vector.
5=-TGAACGCCTGGTTGCCAGTAGGTGGCG
TTAATTAGGGATAACAGGGTAATTA-3
3PROXCRC Reverse complement of 3PROXC.
5=-TAATTACCCTGTTATCCCTAATTAATT
CCACCTACTGGCAACCAGGCGTTCA-3
PROXTOMF Nucleotides 1–50 correspond to nucle
the TOMSmaF primer (missing CC
5=-CGAGCTTTTGAAGATGGCACAATAACT
PROXRFP3 Nucleotides 1–50 correspond to nucle
the URA3R primer.
5=-TGTCCCTACCGTCCTTTTCACTCCAAT
TOMSmaF 5=-CCCGGGATGGTGAGCAAGGGCGAGGA
TOMSpeR 5=-ACTAGTTTACTTGTACAGCTCGTCCA
Ge
PROXSEQF 5=-CCATGTTGTTGTCCTCG-3=
PROXSEQR 5=-AAATCCCAGAGCCTATGC-3=
Generation of URA3 Pro
URA3F 5=-CACACCGCATAGGGTAATAACTG-3=
URA3R 5=-ACCACAGCTTTTCAATTCAATTC-3=
RT-P
PROXRTF1 5=-CCGCAGAAGGACTCTCTTTGTCAC-3
PROXRTR1 5=-CGTCCGAGAAGTAGGTCTTCAGC-3=
MACT1F 5=-GCTGTGCTGTCCCTGTATGCCTCT-3
MACT1R 5=-CCTCTCAGCTGTGGTGGTGAAGC-3=lymph node was surgically exposed as previously de-scribed.24 The lymph node was immersed in 0.9% saline
and was covered with a glass coverslip. An Olympus
BX61WI fluorescence microscope combined with an Olym-
pus 20X, 0.95NA objective (Olympus, Melville, NY) and a
two-photon microscopy system (LaVision BioTec, Bielefeld,
Germany) was used for imaging of the lymph node. An
autotunable titanium-sapphire multipass laser (Chameleon-
XR; Coherent Inc., Santa Clara, CA) pumped by a 12-W
Verdi laser source (Coherent Inc.) was used for the excita-
tion light source. Emitted light was collected using non-
descanned detectors outfitted with the following bandpass
filters: 435/90 nm (for second harmonic emission of colla-
gen fibers), 525/50 nm (GFP), and 615/100 nm (RFP).
Stacks of either 96 or 150 optical sections with 1-m z
spacing were acquired with the laser set at a wavelength of
940 nm. The field of view for each x-y plane was 500 mm,
acquired at a resolution of 0.976 mm per pixel. Volocity
software (PerkinElmer, Waltham, MA) was used to generate
volume renderings of image stacks.
Ex Vivo Fluorescent Microscopy
Tissues were visualized using an Axioskop fluorescent
ence and description
om Transgene
vector. Nucleotides 51–100 correspond to nucleotides
TCGAGGCCGGCGCGCCACCTAGATGGAGCATGTGGCGCATTCC-
CCACATGCTCCATCTAGGTGGCGCGCCGGCCTCGAGGGCCTAG-
167,340–167,389 of RPCI23-385H16. Nucleotides 51–100
GGGGAGGTTTAGGAGATGGATCCGTTTAAACGCGGCCGCTTAA-
GCCGCGTTTAAACGGATCCATCTCCTAAACCTCCCCAACAGCG-
80,936–80,985 of RPCI23-385H16. Nucleotides 51–75 are
’ end).
GTGATGCCTGACCATGACGGGATGGTGAGCAAGGGCGAGGAGG-3=
80,864–80,913 of RPCI23-385H16. Nucleotides 51–75 are
CCCTTCTCCTCTTGGTTTGCACCACAGCTTTTCAATTCAATTC-3=
-3=
ng
Southern Blot Analysis
ersSequ
f ProxT
sperA
GGCCC
ATGCG
=
otides
CTGTT
=
AAGCG
=
otides
at the 5
GTCCA
otides
GTCAA
GG-3=
TGCCG
notypi
be for
CR Prim
=
=microscope (Carl Zeiss MicroImaging GmbH), and im-
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sion software was used for analyses.
mRNA Analysis
Adrenal glands and livers were removed from wild-type
mice, and RNA was purified by the RNeasy spin column
method (Qiagen Inc., Valencia, CA). cDNA was prepared
using SuperScript II enzyme (Invitrogen) and was ana-
lyzed in SYBER Green reactions (iQ supermix; Bio-Rad
Laboratories, Hercules, CA) by real-time PCR (iQ5; Bio-
Rad Laboratories). RT-PCR primers for Prox1 spanning
exons 2 and 3 of mouse Prox1 (192 bp) and mouse
-actin (206 bp) are indicated in Table 1.
Preparation of Bone Marrow and Blood Smears
The mice were anesthetized, and heparinized blood was
collected from the retro-orbital plexus. Smears of blood
and bone marrow cells were prepared, dried, and fixed in
either 4% paraformaldehyde or methanol.
Primary Megakaryocyte Culture and Separation
from Whole Bone Marrow
Primary megakaryocytes were derived from murine bone
marrow. After lysis of mature red blood cells (BD Pharm
Lyse, BD Biosciences, San Jose, CA), bone marrow
cells were cultured at 2  106 cells/mL in StemSpan
serum-free expansion medium (STEMCELL Technolo-
gies Inc., Vancouver, BC, Canada), 30% serum substi-
tute (BIT9500; STEMCELL Technologies Inc.), 50 ng/mL
murine thrombopoietin (PeproTech, Rocky Hill, NJ), 2
mmol/L L-glutamine, and penicillin/streptomycin.25 To en-
rich for megakaryocytes, after 4 days, the cells were
fractionated on a 3% discontinuous bovine serum albu-
min (Sigma-Aldrich) gradient. The fully mature polyploid
megakaryocytes were located mainly in the pellet below
the 3% fraction.26
Human Erythroleukemia Cell Culture
Human erythroleukemia (HEL) cells were purchased from
American Type Culture Collection (Manassas, VA) and
were cultured as described elsewhere.25 HEL cells were
cultured in the presence of 1.5  108 mol/L phorbol
12-myristate 13-acetate (Sigma-Aldrich) for 24 to 72
hours to induce differentiation. Cytoplasmic fractions were
prepared from whole HEL cells by sequential homogeniza-
tion in lysis buffer and were centrifuged at 1300 g saving
the supernatant. The nuclear pellet was resuspended in the
same buffer, ultrasonicated to break the nuclear mem-
branes apart, and centrifuged at 1300  g. The nuclear
fraction was in solution in the supernatant.
Human Lymphatic Endothelial Cell Culture
The commercially available human lymphatic endothelial
cells isolated from human dermal lymphatic microvascu-
lar endothelial cells were purchased from Lonza GroupLtd. (Basel, Switzerland). Human lymphatic endothelial
cells were cultured in EGM-2MV media (Lonza Group
Ltd.) in cell culture dishes coated with 0.1% gelatin (Bio-
Rad Laboratories) at 37°C in 5% CO2 as described pre-
viously.27 Confluent cells were harvested, and protein
was extracted for Western blot analysis.
Western Blot Analysis
Cells were lysed in radioimmunoprecipitation assay buf-
fer (Bio-Rad Laboratories) containing protease inhibitors
(Roche Applied Sciences, Indianapolis, IN). Protein was
boiled, resolved in 4% to 20% polyacrylamide gels (Mini-
Protean TGX; Bio-Rad Laboratories), and transferred to
nitrocellulose membranes (Bio-Rad Laboratories). Mem-
branes were then blocked with either 5% milk or bovine
serum albumin in PBS containing 0.05% Tween 20.
Primary antibodies: rabbit anti-mouse–Prox1 1:1000
(Chemicon, Temecula), rabbit anti-human–Prox1 1:1000
(Abcam Inc.), mouse anti-mouse–actin 1:10,000 (Sigma-
Aldrich), and rabbit anti-human–glyceraldehyde-3-phos-
phate dehydrogenase 1:10,000 (Sigma-Aldrich). Sec-
ondary horseradish peroxidase–conjugated antibodies:
goat anti-rabbit Ig 1:5000 and goat anti-mouse Ig 1:5000
(Santa Cruz Biotechnology). Bands were detected using
an enhanced chemiluminescence detection system (GE
Healthcare Bio-Sciences Corp, Piscataway, NJ).
Results
Transgenic Mice Express the RFP tdTomato
Under the Control of the Prox1 Gene
ProxTom transgenic mice were made on the C57BL/6
background using the pClasper technique.23 A large
genomic DNA fragment was isolated that contained the
entire mouse Prox1 gene and its known regulatory ele-
ments (Figure 1A). Three mice from 27 progenies of mi-
croinjected embryos were positive for the transgene by
PCR (Figure 1B). Southern blot analysis confirmed that
founder mice 12 and 15 contained approximately ten or
six copies of the transgene, respectively (Figure 1C).
Founder 12, with the highest copy number, had brighter
fluorescence than did founder 15. Both mice were
healthy, germline transmission was achieved in C57BL/6
mice with normal mendelian transmission, and lines 12
and 15 were established from founders 12 and 15, re-
spectively. Mice from both lines were used in this study.
Prox1-Driven tdTomato Is Expressed in LVs
Coincident with Endogenous Prox1 and LYVE-1
in Lymph Nodes
Lymphatic endothelial cells from the lymph nodes of trans-
genic mice had a robust red signal in their cytoplasm that
was not seen in littermate controls (Figure 2). The tdTomato
signal was apparent by direct fluorescence in progenies of
founder 12. Line 12 was brighter than line 15, most likely
because it carries a higher number of copies of the trans-
gene (Figure 1C). Although the signal was less bright in line
1720 Truman et al
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binds tdTomato. We co-stained LVs with an anti-Prox1 an-
tibody to check the fidelity of transgene expression. In both
lines, we observed tdTomato in the same cells as endoge-
nous Prox1. tdTomato was detected mainly in the cyto-
plasm, whereas endogenous Prox1 was predominantly
found in the nuclei of LVs (Figure 2A).
LYVE-1 is a marker of LVs that is also expressed by
macrophages.7 We saw that tdTomato co-localized with
LYVE-1 in LVs (Figure 2B) but not in macrophages.
Lymph node macrophages, defined by staining with an-
tibody to CD11b, also expressed LYVE-1 but not tdTo-
mato (Figure 2B). These data demonstrate that Prox-1–
driven tdTomato is a more specific and useful marker for
lymph node LV imaging than is LYVE-1 because CD11b-
positive macrophages from transgene-positive mice do
not express tdTomato (Figure 2C).
LVs Can be Visualized in Living ProxTom Mice
Our goal was to develop a mouse whose LVs could be
visualized in a living animal to conduct immunologic stud-
ies. We wanted to observe the dynamic interaction of LV
with HEV lymph node in real time because of the close
interactions between these vessels that we have ob-
served after immunization.1 We crossed a red fluorescent
ProxTom mouse (from line 12) with an Hec6stGFP mouse
that has green fluorescent HEVs, and their progenies
were immunized with 4% oxazolone. Seven days later,
the popliteal lymph node of a ProxTom  Hec6stGFP
mouse was surgically exposed and examined in vivo us-
Figure 2. LVs can be visualized in ProxTom lymph nodes. A: tdTomato and
Prox1 were co-expressed in lymphatic endothelial cells. tdTomato (red) is in
the cytoplasm, and endogenous Prox1 (green) is in the nuclei of lymphatic
endothelial cells. Nuclei were counterstained with DAPI (blue). B: tdTomato
(red) is expressed in the cytoplasm of lymphatic endothelial cells co-incident
with LYVE-1 (green). Antibodies to LYVE-1 also bind to macrophages in the
lymph node (green; arrowhead). Nuclei were counterstained with DAPI
(blue). C: CD11b-positive macrophages (green) do not express the tdTomato
transgene (red) in the ProxTom lymph node.D: An in vivo three-dimensional
image of a popliteal lymph node acquired by two-photon laser scanning
microscopy. Progeny from a cross between a ProxTom mouse and a
Hec6stGFP mouse with green fluorescent HEVs was imaged, showing tdTo-
mato in LVs (red), HEVs (green), and a blue capsule. All the data are from
ProxTom line 12.ing a two-photon laser scanning microscope. The LVswere fluorescent red and were seen clearly, and the HEVs
were green (Figure 2D). The blue color on the edge of the
lymph node results from “second harmonic” emission gen-
erated by photons interacting with collagen in the capsule.
We imaged tissue immediately beneath the capsule to a
depth of 96 m and obtained stacks of 1-m-thick optical
sections (see Supplemental Video S1 at http://ajp.ampathol-
.org). We also imaged the medulla of the lymph node to a
depth of 150 m (see Supplemental Video S2 at http://
ajp.ampathol.org). The distribution of LVs relative to HEVs in
the subcapsular tissues was revealed by a three-dimen-
sional reconstruction of these image stacks (Figure 2D).
These data confirm the suitability of ProxTommice for in vivo
two-photon laser scanning microscopy.
Prox1-Driven tdTomato Is Expressed in LVs in a
Variety of Tissues and Is Highly Expressed in
Lymphatic Valves
tdTomato fluorescence was seen in LVs in many organs
of mice aged 10 to 16 weeks (Figure 3), and fluorescence
continued to be observed in tissues from older mice (1
year old). We saw tdTomato in LVs in whole mounts of the
following tissues: ear skin, the lacteals and collecting
vessels of the ileum, esophagus, mesentery, diaphragm,
tongue, mucosal and serosal surfaces of a Peyer’s patch,
and bladder (Figure 3). The strongest tdTomato signal
was seen in the valve leaflets in the large collecting
vessels found in the mesentery and draining the esoph-
agus (Figure 3, C and D). There was relatively lower
expression of tdTomato in the segments between the
valves. This finding confirmed previous observations that
Prox1 expression is concentrated in the valve leaflets of
collecting LVs.28 The higher expression of tdTomato in
the valves compared with that of the intervalve segments
suggests that the transgene is regulated in the same way
as the endogenous gene.
Prox1-Driven tdTomato Is Expressed in Some
Extralymphatic Tissues
Prox1 has been described in the lens,12 in hepatocytes13
and in the dentate gyrus of the brain,14 and we confirmed
reliable expression of the transgene in these tissues. The
control liver had some background autofluorescence
(Figure 4A). However, ProxTom hepatocytes from line 12
fluoresced more brightly than did those of littermate con-
trols (Figure 4B). To verify that the red fluorescence seen
in ProxTom liver was not simply autofluorescence, we
used an anti-RFP antibody on transgenic line 15 liver. The
anti-RFP antibody did not bind to control liver (Figure 4C),
but it did detect tdTomato in hepatocytes from line 15
ProxTom mice (Figure 4D). These results confirmed
transgene expression in the liver.
Endogenous Prox1 was observed in the nuclei of cells of
the dentate gyrus of wild-type mice (Figure 4E), and we
confirmed cytoplasmic expression of tdTomato in ProxTom
neurons using an anti-RFP antibody (Figure 4F) but not in
those of littermate controls. The ProxTom lens was brightly
fluorescent (Figure 4G) compared with that of a littermate
head).
yer’s pa
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easy to screen transgene-positive mice under UV light.
Herein, we report for the first time the presence of
Prox1-driven tdTomato in the adrenal medulla of adult
mice. We looked at whole mounts of the adrenal gland
and saw tdTomato in the medulla but not in the cortex
(Figure 4H). Endogenous Prox1 was expressed together
with tdTomato in cells of the adrenal medulla (Figure 4I).
Tyrosine hydroxylase is an enzyme important for the syn-
thesis of adrenaline and noradrenaline in the neuroendo-
crine (chromaffin) cells of the adrenal medulla. tdTomato
was co-expressed in cells labeled by an antibody against
tyrosine hydroxylase, confirming Prox1 expression in the
neuroendocrine cells of the adrenal medulla (Figure 4J).
To confirm the expression of endogenous Prox1 mRNA in
whole adrenal gland and liver, we isolated RNA from
wild-type C57BL/6 mice and analyzed it by quantitative
RT-PCR. We show that Prox1 mRNA is expressed in
adrenal glands and liver (Figure 5).
Prox1 Is Expressed in Megakaryocytes
We saw that ProxTom bone marrow contained tdTomato-
Figure 3. tdTomato is expressed in LVs and valves. Whole mounts of ex vivo
in LVs in different tissues. A: Ear skin. B: Central lacteals and submucosal ly
leaflets (arrowhead). D: Mesentery of the small intestine with valves (arrow
F: The tongue. G and H: The mucosal (G) and serosal (H) surfaces of a Pepositive cells, including large multinucleate cells with theappearance of megakaryocytes (Figure 6A). Having
shown tdTomato expression in megakaryocytes using the
transgenic reporter, we looked for Prox1 in wild-type
megakaryocytes by immunohistochemical analysis. We
double stained bone marrow with anti-Prox1 and anti-
CD41 antibodies because CD41 is a marker of mega-
karyocytes and also of platelets. The results showed that
endogenous Prox1 was detected in the cytoplasm of
megakaryocytes of C57BL/6 mice (Figure 6, B–D). We
confirmed Prox1 expression in megakaryocytes by West-
ern blot analysis (Figure 6, E and F). The predicted mo-
lecular weight of Prox1 is 83 kDa, and, as expected, we
saw a band of this size in lymph node stromal cells. After
culturing C57BL/6 bone marrow to stimulate megakaryo-
cyte maturation, we used a bovine serum albumin gradi-
ent to enrich for large, polyploid megakaryocytes. We
saw a band at approximately 83 kDa in the fraction that
was enriched for megakaryocytes and a much less in-
tense band in the megakaryocyte-depleted bone marrow
(Figure 6E). Thus, by means of three separate methods—
transgene reporter fluorescence, endogenous gene im-
munofluorescence, and Western blot analysis—we dem-
onstrated unequivocally that megakaryocytes express
rom ProxTom mice aged 10 to 16 weeks showing tdTomato (red) expression
s of the ileum. C: An LV encircling the distal esophagus showing the valve
E: The lymphatics follow the course of the muscle fibers in the diaphragm.
tch. I: Urinary bladder. All the data are from ProxTom line 12.tissues f
mphaticProx1 protein.
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We used the HEL cell line to examine the subcellular
location of Prox1. HEL cells can be differentiated into
megakaryocytes by the addition of phorbol 12-myristate
13-acetate.25 We differentiated HEL cells into mega-
Figure 4. Extralymphatic expression of tdTomato and Prox1. A: Background
red autofluorescence in the liver of a transgene-negative littermate. B: Bright
tdTomato signal (red) is above background in ProxTom (line 12) hepato-
cytes. C: Anti-RFP antibody (red) does not bind to transgene-negative litter-
mate control liver. D: Anti-RFP antibody (red) labels tdTomato in ProxTom
liver (line 15). E: Dentate gyrus of the brain. Anti-Prox1 antibody (red) labels
endogenous Prox1 in the nuclei of the neurons of transgene-negative litter-
mates. F: Anti-RFP antibody (red) labels tdTomato in the cytoplasm of
neurons in ProxTom dentate gyrus (line 15). In C to F, nuclei were counter-
stained with DAPI (blue). G: ProxTom in the lens (line 12). H: ProxTom
(arrowhead) in the adrenal gland medulla (line 12). I: Endogenous Prox1
(green) is co-expressed with tdTomato (red) in cells of the adrenal medulla
ProxTom (line 12). J: Neuroendocrine cells of the adrenal medulla co-expressed
tyrosine hydroxylase (green) and tdTomato (red) in ProxTom (line 12).karyocytes for 0 to 72 hours and then separated thecytoplasmic and nuclear fractions. We found that Prox1
protein was predominantly located in the cytoplasmic
fraction of HEL cells and that a smaller amount was
present in the nuclear fraction (Figure 6F). We also ex-
amined HEL cells by immunohistochemical analysis and,
again, showed that Prox1 was predominantly located in
the cytoplasm of HEL cells with a ploidy of 2N to 8N.
Prox1 Is Located in Platelets
Having shown that primary megakaryocytes and HEL
cells express Prox1 in their cytoplasm and knowing that
platelets form by budding off from megakaryocyte cyto-
plasm, we next looked for Prox1 in platelets. We double
stained platelets in whole blood (Figure 7A) and in plate-
let-rich plasma (Figure 7, B–D) with antibodies to Prox1
and CD41 and discovered that platelets carry Prox1,
suggesting that megakaryocytes incorporate Prox1 into
platelets during platelet formation.
Discussion
Our goal was to make a transgenic mouse with red fluo-
rescent LVs suitable for in vivo imaging by two-photon
laser scanning microscopy. We showed that ProxTom
mice have brightly fluorescent LV that can be imaged
directly, without the need for external manipulation or the
injection of fluorescent tracer dyes. Our eventual goal is
to visualize the dynamic changes in the vasculature of the
lymph node after immunization in real time. ProxTom
Figure 5. Prox1 mRNA expression in liver and adrenal glands. A: Expression
levels of endogenous Prox1 mRNA in mouse adrenal gland and liver were
quantified by quantitative RT-PCR relative to mouse -actin and are ex-
pressed as the fold difference in threshold cycle values (2CT) between
Prox1 and -actin. B: Amplification products from the quantitative RT-PCR
analysis were separated on a 2% agarose gel. The composite figure shows the
192-bp Prox1 and 206-bp -actin products from adrenal gland (Adr) and liver
(Liv). M, size marker.
A) for 0
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that have green fluorescent HEVs, which allowed us to
image red LVs and green HEVs simultaneously in a living
lymph node for the first time. The ready visibility of cells
expressing the tdTomato reporter also allowed us to de-
tect Prox1 expression in novel places, leading to the
discovery of Prox1 in the neuroendocrine cells of the
adrenal gland and in megakaryocytes and platelets.
We used the pClasper technique to construct ProxTom
mice because it permits the creation and modification of
transgenes over a wide range of sizes, from a few kilo-
base pairs to entire BAC inserts, accommodating most
genes. pClasper is a shuttle vector capable of propaga-
tion in yeast and bacteria. Constructs are fashioned pre-
cisely by homologous recombination in yeast, whereas
transgene expansion, purification, and storage are per-
formed in bacteria.23 We used pClasper to capture 155
kb of the Prox1 gene, including 80 kb of upstream regu-
latory sequences, which is a much larger segment than
previous LV reporters.8 The 155-kb ProxTom construct
contains the coding regions and control elements neces-
sary for the recapitulation of normal patterns of Prox1
Figure 6. Prox1 in megakaryocytes. A: Bone marrow smear showing ProxT
were counterstained with DAPI (blue). B: Anti-Prox1 antibody (red) labels
C57BL/6. C: The same megakaryocyte stained with anti-CD41 antibody (g
counterstained with DAPI (blue). E:Western blot of Prox1 expression in meg
identifies a band at 83 kDa in lymph node stromal cells. Prox1 is seen in th
lymphatic endothelial cells (HLECs)42 and HEL cells express Prox1. Prox1 is f
into megakaryocytes after culture with phorbol 12-myristate 13-acetate (TP
phosphate dehydrogenase.
Figure 7. Prox1 in platelets. A: Whole blood from C57BL/6 mice showin
counterstained with DAPI (blue). B: Platelet-rich plasma from C57BL/6 mice showing
same platelets stained with anti-CD41 antibody. D: Merged image of B and C.expression (Figure 1A). Integration site position effects
are ameliorated by the fact that the entire gene, sur-
rounded by a large amount of genomic DNA, likely har-
boring insulators, is included in the construct. In our
experience, normal expression is seen in more than 90%
of founders using the pClasper technique.23 The reliabil-
ity of pClasper meant that we were confident that the
transgene would faithfully reproduce endogenous gene
expression. In fact, we could confirm previous reports of
Prox1 expression in adult liver, dentate gyrus, and lens,
and we also discovered Prox1 in megakaryocytes, plate-
lets, and the adrenal medulla.12–14
Prox1 has been described in the sympathetic ganglia
of murine embryos and also in neuroblastomas, which
are tumors of the adrenal medulla.8,29 The sympathetic
ganglion and the adrenal medulla are derived from the
neural crest. Neuronal-derived peptides and transmitters
are important for lymphatic development.30 It will be in-
teresting to see whether the neuroendocrine (chromaffin)
cells of the adrenal medulla release Prox1 after stimula-
tion of the sympathetic nervous system.
e 12) megakaryocyte expression of tdTomato (red) in the cytoplasm; nuclei
nous Prox1 in the cytoplasm of megakaryocytes from a transgene-negative
: Merge showing Prox1 and CD41 (yellow) in the cytoplasm; nuclei were
te (MK)-depleted and MK-enriched bone marrow (BM). Anti-Prox1 antibody
riched fraction and a lesser amount in the MK-depleted fraction. F: Human
edominantly in the cytoplasm of HEL cells. HEL cells that have differentiated
to 72 hours express Prox1 in their cytoplasm. GAPDH, glyceraldehyde-3-
rox1 antibody labeling of platelets (red), erythrocytes (green), and nucleiom (lin
endoge
reen). D
akaryocy
e MK-en
ound prg anti-P
that anti-Prox1 antibody (red) labels endogenous Prox1 in platelets. C: The
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we could verify tdTomato expression by comparing it with
the normal distribution of endogenous Prox1. It was es-
pecially important to check the fidelity of tdTomato fluo-
rescence when we saw it in novel places such as in the
bone marrow and the adrenal medulla. When we con-
structed ProxTom, we inserted the reporter gene in-frame
after the DNA coding for amino acid five (Asp5) in the
Prox1 gene (Figure 1A). This meant that the tdTomato
stop codon was upstream of the Prox1 nuclear localiza-
tion signal and directed tdTomato into the cytoplasm.
The observation that Prox1 is located in megakaryo-
cytes and platelets is interesting given the reported role
of platelets in lymphangiogenesis in the embryo. The
finding that megakaryocytes express Prox1 is consistent
with an earlier report that Prox1 mRNA was observed in
some human leukemias and in the megakaryocyte lines
HEL, CMK86, and MEG01.31 At first, we were puzzled to
find that Prox1 was located predominantly in the mega-
karyocyte’s cytoplasm because Prox1 is a transcription fac-
tor that is usually found in the nucleus. However, similar to
Drosophila prospero, Prox1 can also be in the cytoplasm
under certain circumstances.32–37 We speculated that
Prox1 might be in the cytoplasm of megakaryocytes be-
cause these cells undergo endomitosis, which is an un-
usual mode of DNA replication without cell division. The
amino acid sequence of Prox1, 623WFSNFR628, includes
four residues that are conserved in the consensus pen-
etratin sequence that is also shared by other homeobox
proteins, eg, Pax6 and Engrailed.37,38 The penetratins
are hydrophilic “cell-penetrating” peptides that can cross
lipid membranes and are necessary for nuclear export
and secretion, suggesting that Prox1 may move more
freely between the nucleus and cytoplasm than was ini-
tially appreciated. A previous publication has shown that
single point mutations of this 623WFSNFR628 region can
alter the intracellular distribution of Prox1, indicating its
importance in this function.37
Platelets are required for lymphangiogenesis in embry-
onic development.17–20 It is not known how they contrib-
ute to the separation of the lymphatic sac from the car-
dinal vein, but it has been suggested that platelets
aggregate to form a plug that physically divides the blood
and the LVs. Platelets’ adherence to endothelial cells
expressing podoplanin, by the platelet receptor CLEC2,
activates the SYK/SLP76 pathway in vitro. When bound to
endothelial cells, CLEC2-activated platelets may signal to
the endothelium either through direct cell-to-cell contact
or indirectly via released microvesicles.39 Platelets can
release granules and microvesicles containing transcrip-
tion factors, microRNAs, and growth factors that can in-
fluence endothelial cells.40,41 The observation that Prox1
is in platelets suggests the possibility that these cells may
contribute to lymphangiogenesis in part through delivery
of their contents to target endothelial cells in lymphangio-
genesis in ontogeny and in inflammation.42
In summary, we developed the ProxTom mouse,
whose LVs express red fluorescent tdTomato. The high
visibility of the reporter allows for reliable in vivo imaging.
The extent and content of DNA surrounding the gene
has allowed fidelity of its expression in multiple tissuesand has revealed that the adrenal medulla, mega-
karyocytes, and platelets contain Prox1. Additional in-
sights into the immune response and regulation of LV
function in health and disease will be derived from the
analysis of ProxTom mice.
Note Added in Proof
After acceptance of this manuscript, a paper was pub-
lished that used Prox1 to drive morange2 with expression
in lymphatic vessels.43
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